Latest Publication
01.02.2010
The impact of peritumoral vascular invasion on outcome in IBCSG Trials VIII and IX
235. In this paper Viale and colleagues reviewed the associations between peritumoral vascular invasion (PVI) and outcome in two IBCSG trials testing chemo-endocrine adjuvant therapies in premenopausal (Trial VIII) or postmenopausal (Trial IX) patients with node-negative breast cancer. Presence of PVI was significantly associated with locoregional recurrence and poorer disease-free and OS in Trial VIII, and with poorer DFS in Trial IX. Its impact on response to treatment was also explored.
|